Regulatory Investigations In July 2023, the Icelandic Medicines Agency received reports about suicidal ideation in patients using GLP-1s, and the European Medicines Agency (EMA) initiated a review of a possible association between GLP-1 usage and suicidal ideation
A positive C
A subsequent head-to-head trial, SURMOUNT-5, found that Tirzepatide outperformed Semaglutide with an average weight reduction of 20.2 percent compared to 13.7 percent over the same period, marking the first direct clinical comparison between the two leading GLP-1 medications
Chromium, a key mineral, helps regulate glucose metabolism and controls appetite, making it easier to resist cravings and maintain consistent energy levels
We minimize side effects through gradual dosing and provide management strategies
Peptide Synergy Investigations One major area of interest involves understanding how multiple peptides interact within biological systems